Effects of Prebiotic Oral Healthcare Products as an Adjunct to Non-surgical Periodontal Therapy
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
The aim of this study is to determine the impact of a prebiotic toothpaste and mouthrinse in periodontitis patients as an adjunct to scaling and rootplaning.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2015
CompletedFirst Posted
Study publicly available on registry
August 11, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedMarch 14, 2017
March 1, 2017
July 1, 2015
March 10, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Pocket Probing Depth (PPD) at teeth with residual pockets
Pocket probing depth measured with Merrit B prob
Baseline - 6 months
Study Arms (2)
Prebiotic
EXPERIMENTALThis group will be administered a prebiotic mouthrinse and toothpaste
Control
PLACEBO COMPARATORThis group will be administered a control mouthrinse and toothpaste
Interventions
Eligibility Criteria
You may qualify if:
- patients
- ≥ 36 years of age
- \- Page 4 of 4 \[DRAFT\] -
- No previous scaling and rootplaning
- Clinical diagnosis: severe generalized periodontitis characterized by the presence of \> 14 affected teeth when \> 14 teeth are present (if number of teeth present is \< 14, 8-14 teeth need to be affected) with an attachment loss of \> 6mm prior to initial non-surgical periodontal therapy.
- A minimum of 3 natural teeth in every quadrant
- Willing and able to give written informed consent
You may not qualify if:
- Patients with aggressive periodontitis or necrotizing periodontitis
- Patients who smoke
- Pregnant or lactating woman
- A history of diabetes, rheumatic fever, liver or kidney disease, neurological deficiencies, or use of medication which may affect periodontal tissue, (phenytoin, cyclosporin, nifedipine, chronic use of non-steroidal antiinflammatory drugs)
- Patients with poorly controlled diabetes
- Patients taking bisphosphonate mediation
- Patient who have taken systemic antibiotics 3 months prior to treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 1, 2015
First Posted
August 11, 2015
Primary Completion
December 1, 2017
Last Updated
March 14, 2017
Record last verified: 2017-03